Clinical Trial

Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 14, 2025 (before its estimated February 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
Multicenter, observational, prospective, biological pilot study on liquid biopsy, aimed at investigating methylation profiles in relation to the early diagnosis of bladder cancer, to validate the potential of commercially available tests (e.g. BladderCARE, Bladder EpiCheck), to apply and validate tests based on targeted multi-marker or genome wide analyzes via NGS and to identify methylation profiles as a tool to infer clinical outcome.
Trial Details
NCT Number NCT06878027
Lead Sponsor Regina Elena Cancer Institute
Collaborators: Azienda Ospedaliera Santa Maria Degli Angeli, Istituto per lo Studio, la Prevenzione e la Rete Oncologica
Conditions Bladder Cancer
Enrollment 100 participants
Start Date 2024-08-06
Primary Completion 2026-02-06 (estimated)
Study Completion 2026-02-06 (estimated)
Updated on ClinicalTrials.gov 2025-03-14